Total Payments
$1,383
2024 Payments
$29.84
Companies
15
Transactions
79
Medicare Patients
446
Medicare Billing
$48,408
Payment Breakdown by Category
Food & Beverage$1,326 (95.9%)
Education$56.84 (4.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,326 | 74 | 95.9% |
| Education | $56.84 | 5 | 4.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $327.87 | 16 | $0 (2022) |
| GlaxoSmithKline, LLC. | $193.08 | 14 | $0 (2022) |
| Amarin Pharma Inc. | $185.07 | 3 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $168.46 | 11 | $0 (2018) |
| ABBVIE INC. | $143.64 | 10 | $0 (2024) |
| PFIZER INC. | $109.34 | 5 | $0 (2018) |
| Supernus Pharmaceuticals, Inc. | $59.58 | 4 | $0 (2017) |
| Sunovion Pharmaceuticals Inc. | $56.90 | 5 | $0 (2018) |
| Allergan Inc. | $37.54 | 3 | $0 (2018) |
| Lilly USA, LLC | $35.91 | 3 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $29.84 | 1 | ABBVIE INC. ($29.84) |
| 2022 | $171.35 | 12 | GlaxoSmithKline, LLC. ($135.01) |
| 2021 | $140.55 | 11 | AbbVie Inc. ($113.80) |
| 2020 | $11.20 | 1 | AstraZeneca Pharmaceuticals LP ($11.20) |
| 2019 | $169.74 | 5 | Amarin Pharma Inc. ($120.45) |
| 2018 | $337.60 | 19 | AstraZeneca Pharmaceuticals LP ($118.78) |
| 2017 | $522.74 | 30 | Boehringer Ingelheim Pharmaceuticals, Inc. ($157.72) |
All Payment Transactions
79 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/20/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $29.84 | General |
| Category: NEUROSCIENCE | ||||||
| 12/13/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: RESPIRATORY | ||||||
| 11/22/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.41 | General |
| Category: RESPIRATORY | ||||||
| 10/18/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.59 | General |
| Category: RESPIRATORY | ||||||
| 08/25/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.14 | General |
| Category: RESPIRATORY | ||||||
| 07/21/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.15 | General |
| Category: RESPIRATORY | ||||||
| 06/21/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.93 | General |
| Category: RESPIRATORY | ||||||
| 06/21/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $1.44 | General |
| Category: RESPIRATORY | ||||||
| 05/12/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.15 | General |
| Category: RESPIRATORY | ||||||
| 05/05/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $23.53 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/31/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: RESPIRATORY | ||||||
| 02/17/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.58 | General |
| Category: RESPIRATORY | ||||||
| 02/01/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $12.81 | General |
| Category: Respiratory | ||||||
| 11/09/2021 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Education | In-kind items and services | $11.56 | General |
| Category: Respiratory | ||||||
| 10/25/2021 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: NEUROSCIENCE | ||||||
| 08/10/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.15 | General |
| Category: NEUROSCIENCE | ||||||
| 05/06/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $10.60 | General |
| Category: NEUROSCIENCE | ||||||
| 04/07/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: NEUROSCIENCE | ||||||
| 04/06/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $12.72 | General |
| Category: NEUROSCIENCE | ||||||
| 04/06/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $11.83 | General |
| Category: NEUROSCIENCE | ||||||
| 02/25/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.31 | General |
| Category: NEUROSCIENCE | ||||||
| 02/09/2021 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: Respiratory | ||||||
| 01/28/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $2.06 | General |
| Category: NEUROSCIENCE | ||||||
| 01/25/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.65 | General |
| Category: NEUROSCIENCE | ||||||
| 09/02/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.20 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 37 | 42 | $5,440 | $2,141 |
| 2022 | 3 | 136 | 211 | $26,922 | $15,483 |
| 2021 | 3 | 149 | 237 | $31,198 | $18,849 |
| 2020 | 3 | 124 | 233 | $26,702 | $11,934 |
Total Patients
446
Total Services
723
Medicare Billing
$48,408
Procedure Codes
11
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 19 | 23 | $2,438 | $1,110 | 45.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 18 | 19 | $3,002 | $1,031 | 34.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 63 | 134 | $14,204 | $6,966 | 49.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 46 | 46 | $7,820 | $5,812 | 74.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 27 | 31 | $4,898 | $2,706 | 55.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 59 | 131 | $13,886 | $7,571 | 54.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 47 | 47 | $7,990 | $6,079 | 76.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 43 | 59 | $9,322 | $5,199 | 55.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 71 | 177 | $18,762 | $7,041 | 37.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 41 | 41 | $6,970 | $4,631 | 66.4% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 12 | 15 | $970.00 | $262.07 | 27.0% |
About Dr. Deanne Endy, DO
Dr. Deanne Endy, DO is a Family Medicine healthcare provider based in Steelton, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/27/2008. The National Provider Identifier (NPI) number assigned to this provider is 1609045228.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Deanne Endy, DO has received a total of $1,383 in payments from pharmaceutical and medical device companies, with $29.84 received in 2024. These payments were reported across 79 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($1,326).
As a Medicare-enrolled provider, Endy has provided services to 446 Medicare beneficiaries, totaling 723 services with total Medicare billing of $48,408. Data is available for 4 years (2020–2023), covering 11 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Steelton, PA
- Active Since 02/27/2008
- Last Updated 05/03/2023
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1609045228
Products in Payments
- Vascepa (Drug) $185.07
- TRELEGY ELLIPTA (Drug) $169.69
- SYMBICORT (Drug) $125.04
- JARDIANCE (Drug) $117.52
- FARXIGA (Drug) $114.90
- LYRICA (Drug) $109.34
- VRAYLAR (Drug) $95.05
- QULIPTA (Drug) $48.92
- STIOLTO (Drug) $46.53
- UTIBRON (Drug) $42.45
- BEVESPI AEROSPHERE (Drug) $41.22
- BREZTRI (Drug) $39.56
- UBRELVY (Drug) $37.21
- Nucynta (Drug) $18.17
- SPIRIVA (Drug) $15.53
- Morphabond ER (Drug) $14.54
- Utibron (Drug) $14.45
- BREO (Drug) $13.05
- BASAGLAR (Drug) $12.53
- FORTEO (Drug) $12.26
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Steelton
Daniel Kambic, Do, DO
Family Medicine — Payments: $21,476
Family Medicine $21,476
Kaitlin Plummer, Do, DO
Family Medicine — Payments: $14,016
Family Medicine $14,016
Arif Shaikh, Md, MD
Family Medicine — Payments: $3,394
Family Medicine $3,394
William Wewer, D.o, D.O
Family Medicine — Payments: $3,236
Family Medicine $3,236
Maryjo Szada, Md, MD
Family Medicine
Family Medicine